$7.99
0.364.74%
At close: -
$7.56
-0.43-5.40%
After Hours: Dec 16, 6:18 AM EDT
Comments
Loading...
Addex Therapeutics (ADXN) Forecast
NewsEarningsAddex Therapeutics (ADXN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAddex Therapeutics (NASDAQ:ADXN) Stock Quotes, Forecast and News Summary
Addex Therapeutics Stock (NASDAQ: ADXN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Addex Therapeutics (ADXN) stock?
You can purchase shares of Addex Therapeutics (NASDAQ:ADXN) through any online brokerage.
Who are Addex Therapeutics (ADXN) competitors?
Other companies in Addex Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), T2 Biosystems (NASDAQ:TTOO), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
What is the forecast, or price target, for Addex Therapeutics (ADXN) stock?
Addex Therapeutics has a consensus price target of $30.00.
What is the current price for Addex Therapeutics (ADXN)?
The stock price for Addex Therapeutics (NASDAQ: ADXN) is $7.56 last updated December 16, 2024 at 6:18 AM EST.
Does Addex Therapeutics (ADXN) pay a dividend?
There are no upcoming dividends for Addex Therapeutics.
When is Addex Therapeutics (NASDAQ:ADXN) reporting earnings?
Addex Therapeutics’s Q3 earnings are confirmed for Friday, November 22, 2024.
Is Addex Therapeutics (ADXN) going to split?
There is no upcoming split for Addex Therapeutics.
What sector and industry does Addex Therapeutics (ADXN) operate in?
Addex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.